Last updated on August 2019
The Safety Efficacy and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder
Brief description of study
This study will measure the effects of MET-2 on symptoms of depression and anxiety using preand post-treatment scores for overall depression and anxiety and other symptoms of depression, such as sleep and anhedonia.
Detailed Study Description
This study will measure the effects of MET-2 on symptoms of depression and anxiety using preand post-treatment scores for overall depression and anxiety and other symptoms of depression, such as sleep and anhedonia.
Clinical Study Identifier: NCT04052451